U.S. Patent No. 4,503,067

2 opinions in this collection construe or address U.S. Patent No. 4,503,067. View the patent on Google Patents.

• August 5, 2021 Fed. Cir. GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc., No. 18-1976 (Fed. Cir. Aug. 5, 2021) Affirmed in Part
• October 2, 2020 Fed. Cir. GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc., No. 18-1976 (Fed. Cir. Oct. 2, 2020) Reversed in Part